Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.5%

5 terminated/withdrawn out of 91 trials

Success Rate

89.4%

+2.9% vs industry average

Late-Stage Pipeline

11%

10 trials in Phase 3/4

Results Transparency

10%

4 of 42 completed trials have results

Key Signals

8 recruiting4 with results

Enrollment Performance

Analytics

N/A

20(48.8%)

Phase 2

10(24.4%)

Phase 3

7(17.1%)

Phase 4

3(7.3%)

Phase 1

1(2.4%)

41Total

N/A(20)

Phase 2(10)

Phase 3(7)

Phase 4(3)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (91)

Showing 20 of 91 trials

NCT07347275Phase 3Not Yet Recruiting

A Novel Extracorporeal Liver Support Therapy In ALCF and to Evaluate the Efficacy of DIALIVE 2.0, a Liver Dialysis Device.

Role: collaborator

NCT05315570Not ApplicableCompleted

Big Data for Quality of Life in Head and Neck Cancer

Role: collaborator

NCT07243262Recruiting

Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)

Role: collaborator

NCT05727020Recruiting

Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma

Role: collaborator

NCT07054073Recruiting

HCMR Re-Imaging Study

Role: collaborator

NCT04337450Phase 2Active Not Recruiting

DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old

Role: collaborator

NCT06895746Active Not Recruiting

Multi-omics Study in Citrin Deficiency

Role: collaborator

NCT07294794Not ApplicableNot Yet Recruiting

Personalised Pharmacometabolomic-guided Strategy Trial to Optimise Treatment for Hypertension

Role: collaborator

NCT07235579Completed

Understanding Cauda Equina Syndrome

Role: collaborator

NCT04902352Not ApplicableActive Not Recruiting

The DISSECT Study: Effect of Peri-aDventItial SMA diSsECtion on Margin sTatus During Pancreaticoduodenectomy for Resectable Pancreatic Cancer

Role: lead

NCT05714917Recruiting

Neurological Recovery Following NOS-SACD

Role: collaborator

NCT03983707Completed

A Evaluation of the Utilisation, Effectiveness and Safety of Purastat® in the Management of Gastrointestinal Bleeding

Role: collaborator

NCT04700826Phase 4Recruiting

Preventing Stroke, Premature Death and Cognitive Decline in a Broader Community of Patients With Atrial Fibrillation

Role: collaborator

NCT03305250Not ApplicableActive Not Recruiting

Arrhythmia Burden, Risk of Sudden Cardiac Death and Stroke in Patients With Fabry Disease

Role: lead

NCT06894524Not Yet Recruiting

Retrospective Clinical Validation of HepatoPredict

Role: collaborator

NCT05412758Not ApplicableRecruiting

Augmented Response of Volatile Biomarkers in Assessment of Oesophagogastric Cancer (AROMA 1 / BIORESOURCE)

Role: collaborator

NCT04909385Completed

TB PCR in BAL and EBUS-TBNA

Role: collaborator

NCT04025762Not ApplicableCompleted

24/7 Closed-loop in Older Subjects With Type 1 Diabetes

Role: collaborator

NCT03911297Recruiting

DAISy-PCOS Phenome Study - Dissecting Androgen Excess and Metabolic Dysfunction in Polycystic Ovary Syndrome

Role: collaborator

NCT01726374Phase 3Completed

Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours

Role: collaborator